New York Life Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,507
| Closed | -$365K | – | 1185 |
|
|
2024
Q1 | $365K | Buy |
12,507
+3,980
| +47% | +$116K | ﹤0.01% | 1095 |
|
|
2023
Q4 | $288K | Sell |
8,527
-197
| -2% | -$6.65K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $268K | Sell |
8,724
-1,375
| -14% | -$42.2K | ﹤0.01% | 1221 |
|
|
2023
Q2 | $405K | Sell |
10,099
-1,488
| -13% | -$59.6K | ﹤0.01% | 986 |
|
|
2023
Q1 | $473K | Buy |
+11,587
| New | +$473K | 0.01% | 1039 |
|